Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Germany

 

Fresenius to sell Curalie after De Meo’s discreet departure

Fresenius’ digital health subsidiary Curalie is reportedly up for sale, as the conglomerate’s CEO continues to win over investors, streamline the group, and replace management. Meanwhile HBI hears former Helios CEO Francesco De Meo may be unhappy with the circumstances of his departure - and could seek legal advice.

Post Covid regulations in Spain could lead to care home closures

New regulations designed to protect an aging Spanish population post-Covid could see older, outdated care homes forced to close. HBI speaks to Alberto Fernandez, CEO of Madrid-based REIT Healthcare Activos to find out more about the risks and opportunities this presents.

Helios CEO Francesco De Meo leaves with little fanfare

Fresenius Helios has a new CEO. Germany’s largest hospital group by revenue and subsidiary of Germany-based conglomerate Fresenius announced the news in a press release which ignores outgoing Francesco De Meo’s significant and longstanding contribution to the group.

End of Covid windfall sends Sonic’s share price to six-month low

Sonic's share price has been hovering around the A$32 mark for the past three weeks, after falling 5% in response to FY23 results released on August 16, which showed declining profits due to Covid testing winding down. This is the lowest the share price has been in the past six months.

German doctors demand more money as outpatient sector “faces collapse”

Germany’s National Association of Statutory Health Insurance Physicians (KBV) has put a series of demands to the Ministry of Health. These include sustainable, inflation-linked financing, more training and digitisation and less bureaucracy. The group says that if its demands are not implemented the outpatient sector is at risk of collapsing.

Counting the Cost: The impact of inflation on Europe’s health care market

What impact has the high inflation of the past 18 months had on growth in Europe’s health care market? Have for-profit operators been able to pass on cost increases to payors? And have patients paying out of pocket, in the face of rising prices and squeezed budgets, cut back at all? In this first instalment to answer these questions, we focus on the for-profit hospital, imaging and nursing home sectors in the UK, France and Germany.

Fresenius shares rocket to one year high

Germany-based healthcare conglomerate Fresenius SE is trading at its highest share price in over a year – and three high-profile investment banks predict things will get even better.

Interview – Ingeborg Oie, CFO and Chief Strategy Officer, Huma 

In this wide ranging interview we discuss the future of remote patient monitoring (RPM) software and government progress in ehealth. Through its RPM platform,  Huma claims to massively cut costs and improve outcomes for patients with chronic conditions.

Find Us